JPRN-UMIN000001482已完成2 期
Phase II Clinical trial of personalized peptide vaccine for cancer patients - Personalized peptide vaccine trial for cancer patients
Kurume University Cancer Vaccine Center0 个研究点目标入组 150 人开始时间: 2008年11月5日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The following patients must be excluded: 1) Patients with severe symptoms (active and severe infectious disease, circulatory disease, respiratory disease, kidney disease, immunodeficiency, disturbance of coagulation etc). 2) Patients with the past history of severe allergic reactions. 3) Pregnant, nursing, or who wants pregnancy. Patients with no acceptance of use effective contraception during and for at least 70 days after study participation. 4) Patients who are judged inappropriate for the clinical trial by doctors.
研究者
相似试验
已完成
2 期
Phase II Clinical trial of personalized peptide vaccine for cancer patients - Effect of extended dose interval on the immun inductionmalignant tumorJPRN-UMIN000006927Kurume University Cancer Vaccine Center60
已完成
2 期
Phase II Clinical trial of personalized peptide vaccine for patients with maligant tumors (gastrointestinal cancers, hepato-biliary-pancreatic cancers, thoracic malignant tumors, non-epithelial malignant tumors, genitourinary cancers, gynecological cancers, breast cancers, and rare cancers) - Effect of extended interval dosing on immune responsesmalignant tumorJPRN-UMIN000011230Kurume University CanCER Vaccine Center800
已完成
2 期
Phase II Clinical trial of personalized peptide vaccine for patients with various types of cancers - Effect of sequencial change of vaccine antigensmalignant tumorJPRN-UMIN000010068Kurume University Cancer Vaccine Center100
已完成
2 期
Phase II clinical trial of personalized peptide vaccination for standard therapy failed or unoperable Pancreatic cancer patientsPancreatic cancerJPRN-UMIN000001881Kurume University Cancer Vaccine Center100
已完成
2 期
Phase II clinical trial of personalized peptide vaccination for Prostate cancer patientsProstate cancerJPRN-UMIN000003028Kurume University Cancer Vaccine Center100